MITSUBISHI TANABE PHARMA CORP.

In News

Mitsubishi Tanabe Pharma America is Now Tanabe Pharma America - PR Newswire

PR Newswire - Dec 01, 2025

Tanabe Pharma shifts gears for Bain-backed future, dropping Mitsubishi moniker after $3.3B deal - Fierce Pharma

Fierce Pharma - Dec 01, 2025

New owner for Mitsubishi Tanabe Pharma - The Pharma Letter

The Pharma Letter - Jul 02, 2025

Shionogi completes $2.5B deal for ALS drug Radicava rights (updated) - NJBIZ

NJBIZ - Apr 03, 2026

Mitsubishi Tanabe Pharma forms targeted alpha therapy collaboration in Japan - BioWorld News

BioWorld News - Jul 11, 2025

Bain Capital to Acquire Mitsubishi Tanabe Pharma Corporation - Bain Capital

Bain Capital - Feb 07, 2025

Mitsubishi Tanabe’s Co-Promotion of Janssen’s Stelara® to End on 31 December 2025 in Japan - Pearce IP

Pearce IP - Sep 16, 2025

Tanabe Pharma's oral drug scores in ph. 3 rare disease study, though details remain in the dark - Fierce Biotech

Fierce Biotech - Jan 20, 2026

Shionogi Expands Rare Disease Presence with Planned Acquisition of Global Rights to Tanabe Pharma Corporation’s RADICAVA ORS® (edaravone) and IV RADICAVA - Business Wire

Business Wire - Dec 22, 2025

Mitsubishi Tanabe Names New CEO In C-Suite Reshuffle - Citeline News & Insights

Citeline News & Insights - Sep 01, 2025

GV20 Therapeutics Announces Achievement of Milestone under Antibody-Drug Conjugate Collaboration with Mitsubishi Tanabe Pharma Corporation - PR Newswire

PR Newswire - Nov 25, 2025

Mitsubishi Tanabe Pharma Canada is Now Tanabe Pharma Canada - Newswire Canada

Newswire Canada - Dec 01, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment